LU87080A1 - Compositions pharmaceutiques contenant des pyranoquinoleines - Google Patents

Compositions pharmaceutiques contenant des pyranoquinoleines Download PDF

Info

Publication number
LU87080A1
LU87080A1 LU87080A LU87080A LU87080A1 LU 87080 A1 LU87080 A1 LU 87080A1 LU 87080 A LU87080 A LU 87080A LU 87080 A LU87080 A LU 87080A LU 87080 A1 LU87080 A1 LU 87080A1
Authority
LU
Luxembourg
Prior art keywords
composition according
presented
pharmaceutically acceptable
administration
pyrano
Prior art date
Application number
LU87080A
Other languages
English (en)
French (fr)
Inventor
P Dr Wright
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of LU87080A1 publication Critical patent/LU87080A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU87080A 1986-12-19 1987-12-18 Compositions pharmaceutiques contenant des pyranoquinoleines LU87080A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630419A GB8630419D0 (en) 1986-12-19 1986-12-19 Pharmaceutical formulation
GB8630419 1986-12-19

Publications (1)

Publication Number Publication Date
LU87080A1 true LU87080A1 (fr) 1988-04-05

Family

ID=10609308

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87080A LU87080A1 (fr) 1986-12-19 1987-12-18 Compositions pharmaceutiques contenant des pyranoquinoleines

Country Status (17)

Country Link
EP (1) EP0272057A3 (xx)
JP (1) JPS63233919A (xx)
KR (1) KR880007077A (xx)
AU (1) AU8319587A (xx)
BE (1) BE1000733A3 (xx)
CH (1) CH672599A5 (xx)
DK (1) DK669287A (xx)
FR (1) FR2608429A1 (xx)
GB (1) GB8630419D0 (xx)
GR (1) GR871915B (xx)
IE (1) IE873463L (xx)
IL (1) IL84857A0 (xx)
IT (1) IT8723114A0 (xx)
LU (1) LU87080A1 (xx)
NZ (1) NZ222966A (xx)
PT (1) PT86415B (xx)
ZA (1) ZA879416B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058129T3 (es) * 1986-12-23 1994-11-01 Fisons Plc Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.
EP0294914A3 (en) * 1987-03-17 1990-10-10 FISONS plc Nedocromil for the treatment of dermatological disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA735221B (en) * 1972-08-07 1974-07-31 Upjohn Co Improved dosage regimen
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
GB2187953B (en) * 1986-03-15 1989-11-15 Fisons Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
EP0272057A3 (en) 1989-01-11
PT86415A (en) 1988-01-01
JPS63233919A (ja) 1988-09-29
AU8319587A (en) 1988-06-23
EP0272057A2 (en) 1988-06-22
IT8723114A0 (it) 1987-12-18
GB8630419D0 (en) 1987-01-28
KR880007077A (ko) 1988-08-26
IE873463L (en) 1988-06-19
FR2608429A1 (fr) 1988-06-24
CH672599A5 (xx) 1989-12-15
PT86415B (pt) 1990-11-20
DK669287A (da) 1988-06-20
NZ222966A (en) 1990-03-27
ZA879416B (en) 1988-10-26
GR871915B (en) 1988-04-05
DK669287D0 (da) 1987-12-18
BE1000733A3 (fr) 1989-03-21
IL84857A0 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
US5206029A (en) Medicament and its production and use in the treatment of pain, inflammation and fever in man and animals
FR2613934A1 (fr) Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl) methyl)-4h-carbazol-4-one et de la ranitidine, son procede de fabrication, l'utilisation de ses deux principes actifs pour la fabrication d'un medicament
AU9814398A (en) Ibuprofen composition
CH679373A5 (xx)
TW201109015A (en) DP2 antagonist and uses thereof
JP2009513604A (ja) 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
EP1800669A1 (fr) Composition pharmaceutique orodispersible pour administration orale, oromucosale ou sublinguale d'agomelatine
JP2002529407A (ja) L−dopaエチルエステル含有分散性組成物
AU2001270484B2 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
NO20101777L (no) Orodispergerbare tabletter
JP2022103387A (ja) 吸湿性成分を含有する錠剤及びその製造方法
BE1005115A5 (fr) Compositions pharmaceutiques contenant des derives de furanne.
TWI230618B (en) Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
LU87080A1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
CN101264065A (zh) 消旋卡多曲滴丸及其制备方法
US6030643A (en) Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
CH629960A5 (fr) Composition pharmaceutique.
TW200400817A (en) Use of selective EP4 receptor agonists for the treatment of liver failure loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
JP2000026292A5 (xx)
BE1000265A3 (fr) Nouvelle association medicamenteuse.
LU84429A1 (fr) A titre de medicaments,certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
CA2542752A1 (fr) Compositions pharmaceutiques a base de sel d'idazoxan ou l'un de ses polymorphes
FR2551974A1 (fr) Preparation de dobutamine pour l'administration orale
JP3061445B2 (ja) 血管拡張剤